Spinal administration of selective opioid antagonists in amphibians: Evidence for an opioid unireceptor

Life Sciences

Volumn 64, Issue 10, 1999, Pages

  Stevens, Craig W ^a   Newman, Leslie C ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Amphibian; Morphine; Opioid antinociception; Opioid receptor; Unireceptor

Indexed keywords

BETA FUNALTREXAMINE; DELTA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NALTRINDOLE; NORBINALTORPHIMINE; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; EVOLUTION; FEMALE; FROG; INTRASPINAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MALE; NONHUMAN; RECEPTOR INTRINSIC ACTIVITY;

AMPHIBIA; ANIMALIA; ANURA; MAMMALIA; RANA PIPIENS; RANA SP.; VERTEBRATA;

EID: 0033613883     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00013-2     Document Type: Article

References (26)

1. C.W. Stevens and P.D. Pezalla, Life Sci. 33 2097-2103 (1983).
2. C.W. Stevens and P.D. Pezalla, Brain Res. 301 171-174 (1984).
3. C.W. Stevens, P.D. Pezalla and T.L. Yaksh, Brain Res. 402 201-203 (1987).
4. C.W. Stevens and K. Kirkendall, Life Sci. 52 PL111-116 (1993).
5. C.W. Stevens, A.J. Klopp and J.A. Facello, J.Pharmacol.Exp.Ther. 269 1086-1093 (1994).
6. C.W. Stevens and K. Rothe-Skinner, Eur.J.Pharmacol. 331 15-21 (1997).
7. C.W. Stevens, J.Pharmacol.Exp.Ther. 276 440-448 (1996).
8. E.J. Simon, J.M. Hiller, J. Groth, Y. Itzhak, M.J. HollAnd and S.G. Beck, Life Sci. 31 1367-1370 (1982).
9. M. Wollemann, S. Benyhe and J. Simon, Life Sci. 52 599-611 (1993).
10. C. Mollereau, A. Pascaud, G. Baillat, H. Mazarguil, A. Puget and J.C. Meunier, Eur.J.Pharmacol. 150 75-84 (1988).
11. S. Benyhe, E. Varga, J. Hepp, A. Magyar, A. Borsodi and M. Wollemann, Neurochem.Res. 15 899-904 (1990).
12. A.E. Takemori, Ann.Rev.Pharmacol.Toxicol. 25 193-223 (1985).
13. A.E. Takemori and P.S. Portoghese, Ann.Rev.Pharmacol.Toxicol. 32 239-269 (1992).
14. Q.I. Jiang, J.S. Heyman, R.J. Sheldon, R.J. Koslo and F. Porreca, J.Pharmacol.Exp.Ther. 252 1006-1011 (1990).
15. F. Porreca, H.I. Mosberg, J.R. Omnaas, T.F. Burks and A. Cowan, J.Pharmacol.Exp.Ther. 240 890-894 (1987).
16. C.W. Stevens and T.L. Yaksh, J.Pharmacol.Exp.Ther. 238 833-838 (1986).
17. J.C. Hunter, G.E. Leighton, K.G. Meecham, S.J. Boyle, D.C. Horwell, D.C. Rees and J. Hughes, Br.J.Pharmacol. 101 183-189 (1990).
18. E. Mjanger and T.L. Yaksh, J.Pharmacol.Exp.Ther. 258 544-550 (1991).
19. M. Sofuoglu, P.S. Portoghese and A.E. Takemori, J.Pharmacol.Exp.Ther. 257 676-680 (1991).
20. P.J. Tiseo and T.L. Yaksh, Eur.J.Pharmacol. 236 89-96 (1993).
21. A.E. Takemori, B.Y. Ho, J.S. Naeseth and P.S. Portoghese, J.Pharmacol.Exp.Ther. 246 255-258 (1988).
22. W.R. Moyle, R.K. Campbell, R.V. Myers, M.P. Bernard, Y. Han and X. Wang, Nature 368 251-254 (1994).
23. R.K. Campbell, E.R. Bergert, Y. Wang, J.C. Morris and W.R. Moyle, Nature Biotechnology 15 439-443 (1997).
24. M.G. Darlison, F.R. Greten, R.J. Harvey, H. Kreienkamp, T. Stuhmer, H. Zwiers, K. Lederis and D. Richter, Proc.Natl.Acad.Sci.USA 94 8214-8219 (1997).
25. Stefano, G.B., Comp. Biochem. Physiol. C 90 287-294 (1988).
26. Salzet, M. and G.B. Stefano, Brain Res. 768 224-232 (1997).